3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
46
Lung Neoplasms
29
Neoplasms
26
Colorectal Neoplasms
21
Prostatic Neoplasms
16
Uterine Cervical Neoplasms
9
Fatigue
9
Hematologic Neoplasms
8
Lymphoma
7
Hematopoietic and Lymphatic System Neoplasm
7
Anxiety Disorders
7
Papillomavirus Infections
6
Melanoma
6
Neoplasm Metastasis
5
Multiple Myeloma
5
Gastrointestinal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Skin Neoplasms
4
Ovarian Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Obesity
4
Motor Activity
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Neoplasms
4
Depression
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Interventions
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Topiramate
1
Tirzepatide
1
Surveys and Questionnaires
1
Qsymia
1
Pulse Wave Analysis
1
Phlebotomy
1
Phentermine
1
Naltrexone
1
Metformin
1
Magnesium
1
Liraglutide
1
Glucagon-Like Peptide-1 Receptor
1
Exercise Test
1
Electrocardiography
1
Educational Status
1
Echocardiography
1
Diethylpropion
1
Carnitine
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dyslipidemias
×
Educational Status
×
Clear all
NCT03104543
2024-03-06
CHIIP
Fred Hutchinson Cancer Center
Phase NA
Completed
347 enrolled
10 charts